Hydrothermal extraction of hemicellulose: from lab to pilot scale.

Bioresour Technol

Department of Chemical Engineering and Environmental Technology, High Pressure Processes Group, University of Valladolid, Valladolid ES-47011, Spain. Electronic address:

Published: January 2018

A flow-through reactor for hemicelluloses extraction with hot pressurized water was scaled with a factor of 73. System performance was evaluated by comparing the temperature profile, extraction yield and kinetics of the two systems, performing experiments at 160 and 170°C, 11barg for 90min, using catalpa wood as raw material. Hemicellulose yields were 33.9% and 38.8% (lab scale 160°C and 170°C) and 35.7% and 41.7% (pilot scale 160°C and 170°C). The pilot reactor was upgraded by designing a manifold system capable to provide samples with different liquid residence time during the same experiment. Tests at 140, 150, 160 and 170°C were carried for 90min. Increasing yields (9.3-40.6%) and decreasing molecular weights (4078-1417Da) were obtained at increasing the temperature. Biomass/water ratio of 1/27 gave total average concentration of xylose of 0.4g/L (140°C) to 1.8g/L (170°C).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biortech.2017.09.155DOI Listing

Publication Analysis

Top Keywords

pilot scale
8
160 170°c
8
scale 160°c
8
160°c 170°c
8
170°c
5
hydrothermal extraction
4
extraction hemicellulose
4
hemicellulose lab
4
lab pilot
4
scale flow-through
4

Similar Publications

Bioplastics, particularly polyhydroxyalkanoates (PHAs), are emerging as promising alternatives to traditional materials due to their biodegradability. This study focuses on the production of PHAs as bioplastics using effluent from hydrogen production in a two-stage Biohythane Pilot Plant, which provides a low-cost substrate. The aim is to optimize production conditions, with Cupriavidus necator TISTR 1335 being used as the PHA producer.

View Article and Find Full Text PDF

This study investigates the impact of internalized HIV stigma on sleep problems and depression in people living with HIV (PLWH) in Botswana. It also explores whether sleep problems mediate the relationship between internalized HIV stigma and depressive symptoms, given that sleep disturbance is a symptom of depression and often predates a depressive episode. Secondary analysis was conducted using baseline data from a pilot randomized controlled trial on 58 virally unsuppressed PLWH in Gaborone, Botswana.

View Article and Find Full Text PDF

Single minimal conjunctival incision for rectus muscles: a pilot feasibility study.

Ther Adv Ophthalmol

January 2025

Instituto Ramón Castroviejo de Investigaciones Oftalmológicas, Madrid, Spain.

Background: Small conjunctival incision size is desirable in strabismus surgery under topical anesthesia.

Objective: To study the feasibility and tolerability of a small bulbar conjunctival incision (SB).

Design: Non-randomized feasibility pilot study.

View Article and Find Full Text PDF

Objectives: This study aimed to assess the feasibility of an online compassion training program for nursing students and preliminarily investigate its effects on mindfulness, self-compassion, and stress reduction.

Methods: This study employed a randomized controlled trial design. Second-year students from a nursing college in Guangzhou, China, were recruited as research participants in August 2023.

View Article and Find Full Text PDF

Background: Acne vulgaris (acne) is a common disorder with a complex, multi-faceted pathophysiology. To date, there has not been a single topical treatment that targets all aspects of acne pathophysiology (ie, increased sebum production, presence of , inflammation, and follicular hyperkeratinization). As such, topical treatments need to be utilized in combination to target all four of the major recognized pathophysiologic components in acne lesion formation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!